High Resolution Nucleic Acid Separation Technologies Capture
Significant Share in Large Nucleic Acid Electrophoresis Market
Nucleic
Acid Separation Life Science Dashboard™
Market Research Report Released by Percepta
Associates Reveals Trend Towards Higher Resolution Separation
Methods Driven by Fastest Growing Nucleic Acid Separation Sub-Segments
CARLSBAD, Calif. (Business Wire EON/PRWEB ) November 10, 2008 --
Percepta Associates announced today the release of Series
One of its Nucleic Acid Separation Life Sciences Dashboard™
market research report. This report, which analyzes key
market indicators in specific nucleic acid separation markets, reveals
that several application segments are growing more than twice the rate
of the overall market average. Faster growth in
sub-segments such as cRNA analysis, small RNA analysis, and mutation
detection coincides with increasing need for higher resolution
separation technologies and is driving share capture for companies such
as Agilent (NYSE: A), Bio-Rad Laboratories (AMEX: BIO), and Applied
Biosystems (NYSE: ABI). Agarose based methods are still
extensively used for other growth segments such as HLA typing. Suppliers
such as Sigma-Aldrich (NASDAQ: SIAL), and Invitrogen (NASDAQ: IVGN) lead
these segments.
Nucleic acid separation techniques include: self made agarose or
polyacrylamide gels, precast agarose or polyacrylamide gels, capillary
electrophoresis, or lab-on-chip microfluidic methods. Nucleic acid
separation is a time tested means of analyzing nucleic acid samples for
multiple applications and is regularly performed in most life science
laboratories.
Product application segments analyzed in Series One of the new Nucleic
Acid Separation Life Science DashboardTM
include:
-
Analyzing amplified DNA (includes AFLP)
-
Analyzing restriction digested DNA (includes RFLP)
-
Analyzing cRNA or total RNA quality
-
Analyzing small RNA molecules
-
Analyzing synthetic DNA or RNA
-
STR analysis
-
HLA typing analysis
-
Pulsed field gel electrophoresis (includes mapping)
-
Mutation detection (includes SSCP, DGGE)
“This report covers the
nucleic acid separation market in great detail, by both application
segment and product type,” said
Mike Klein of Percepta. “Top
suppliers for each technique are segmented by geography and by customer
type. It’s
clear that non agarose based methods have helped some suppliers carve
out healthy and growing market niches. Analysis of
supplier market share by geography and customer type uncovers potential
opportunities for second and third tier competitors to gain share.”
To view nucleic acid separation market research sample data
and questionnaires visit: www.perceptaassociates.com/publications/08_nucleic_acid_overview.shtml
Life Science Dashboards™
are readily accessible sources of current, segment-specific, market
research. Designed and implemented by industry veterans, each dashboard
provides key life science market indicators compiled from the survey
responses of qualified decision-makers and researchers actively using
life science research products. Unlike other market research reports,
Percepta's Dashboards feature an “at-a-glance”
format that provides rapid access to actionable key market indicators in
an easy to understand framework, including:
-
Market size
-
Market share
-
Market growth and reaction throughput rates
-
Customer satisfaction
-
Propensity to switch
-
Competitive intensity
-
Perceived pricing
-
Top suppliers
-
Technique usage frequency
-
Fastest growing techniques
-
Primary and secondary downstream applications
About Percepta
Founded in 2005 in Carlsbad, California Percepta Associates
serves a rapidly growing roster of bioscience clients across North
America and Europe. Percepta is a specialized consultancy providing
expert market research, strategic business planning, portfolio
management, product and corporate branding and marketing communications
services. Percepta also publishes the Trends & Opportunities in
Early Growth Markets series of reports providing perspectives on
the dynamic nature of early growth markets for supply companies and
investors. For more information visit http://www.perceptaassociates.com/index.shtml
See the original story at: http://eon.businesswire.com/releases/nucleic_acid/acid_separation/prweb1596164.htm
Post Comment: Trackback URL: http://www.prweb.com/pingpr.php/U3F1YS1FbXB0LUhvcnItSGFsZi1UaGlyLVNpbmctWmVybw==
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|